The elevation is dose-dependent up to a saturation point, which research places at approximately 1 mcg per kilogram of body weight per injection
Summary: Microdosing GLP-1 for Hashimoto's is an unapproved, off-label practice lacking clinical evidence, and the NHS does not recommend GLP-1 receptor agonists for thyroid conditions without concurrent type 2 diabetes or obesity meeting specific criteria
However, the "Ozempic era" may have changed all that, Tsai's team said
So if you don't love it, you can get your money back
A specific role for IGF-1 receptor (IGF-1R) signaling in the mediation of mammalian longevity was first established in IGF-1R haploinsufficient mice, which lived 33% longer than controls, but unlike other models of reduced somatotropic signaling, this effect was female specific 6